Detalhe da pesquisa
1.
Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study.
Ann Intern Med
; 176(3): 303-310, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802754
2.
Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Clin Gastroenterol Hepatol
; 10(3): 303-8, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22037429
3.
Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO).
Dig Liver Dis
; 54(12): 1623-1629, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100516
4.
Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO).
Dig Liver Dis
; 53(10): 1221-1227, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312103
5.
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.
Clin Gastroenterol Hepatol
; 7(9): 981-7, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19523534
6.
Reduced endothelial progenitor cell number and function in inflammatory bowel disease: a possible link to the pathogenesis.
Am J Gastroenterol
; 104(10): 2500-7, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19568231
7.
Clinical presentation and diagnosis of intestinal adenocarcinoma in Crohn's disease: analysis of clinical predictors and of the life-time risk.
J Gastrointest Surg
; 14(11): 1746-51, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20628906
8.
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.
J Crohns Colitis
; 4(2): 194-8, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21122505
9.
Successful prophylaxis with valaciclovir for relapsing HSV-1 in a girl treated with infliximab for moderate Crohn's disease.
Eur J Gastroenterol Hepatol
; 21(9): 1095-6, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19430300